In an attempt to discover novel biomarker proteins in type 2 diabetes prognosis, we investigated the influence of hypoglycemic extracellular polysaccharides (EPS) obtained from the macrofungus Tremella fuciformis on the differential levels of plasma proteins in ob/ob mice using two-dimensional gel electrophoresis (2-DE). The 2-DE analysis demonstrated that 92 spots from about 900 visualized spots were differentially regulated, of which 40 spots were identified as principal diabetes-associated proteins. By comparing control with EPS-fed mice, we found that at least six proteins were significantly altered in ob/ob mice, including Apo A-I, IV, C-III, E, retinol-binding protein 4, and transferrin, and their levels were interestingly normalized after EPS treatment. Western blot analysis revealed that the altered levels of the two regulatory molecules highlighted in diabetes and obesity (e.g., resistin and adiponectin) were also normalized in response to EPS. The Mouse Diabetes PCR Array profiles showed that the expression of 84 genes related to the onset, development, and progression of diabetes were significantly downregulated in liver, adipocyte, and muscle of ob/ob mice. EPS might act as a potent regulator of gene expression for a wide variety of genes in ob/ob mice, particularly in obesity, insulin resistance, and complications from diabetes mellitus.
Recently, the search for appropriate hypoglycemic agents has been done using diverse macrofungi, owing to the various side effects and toxicity raised by current synthetic antidiabetic drugs [11, 36, 37, 65] . Many investigators have studied the hypoglycemic effect of the fruiting body or mycelia from various macrofungi because of their marked antidiabetic activities, whereas the identity of bioactive ingredients responsible for hypoglycemic activity was not clearly elucidated [7, 15, 27, 29, 30] .
Tremella fuciformis is a medicinal mushroom used as a folk medicine for a variety of human diseases in several Asian countries. It was reported that intraperitoneal and oral administration of an acidic polysaccharide from fruit bodies of several species of Tremella had significant hypoglycemic activity in mice with streptozotocin-induced and genetic diabetes [28] . We also observed a strong hypoglycemic activity of the extracellular polysaccharides (EPS) obtained from mycelial culture of T. fuciformis in ob/ob mice [3] .
In our previous proteomics studies, differential changes of plasma proteins after treatment with streptozotocin (STZ, a diabetogenic chemical) and its reversal by EPS (from the macrofungus Phellinus baumii) were observed [31, 32] . However, the mechanism of the reversal of the protein expression profile by EPS was not clearly addressed.
Serum proteome analysis by the combination of 2-DE and mass spectrometry is a powerful method to study the protein expression profile on a large scale and has contributed significantly to the identification of marker proteins and pathways involved in diabetes development [33, 46, 48, 52, 54] . To systematically characterize the reversal of the protein expression in diabetic animals by EPS, we employed such proteomic method, and validated the changes by Western blotting and PCR array profiling methods.
MATERIALS AND METHODS

Preparation of the EPS
The fungus Tremella fuciformis DG-02 was isolated from a mountainous district in Korea. To prepare the EPS sample, a submerged culture of T. fuciformis was performed as described previously [4] . Briefly, T. fuciformis was cultivated under the following conditions: glucose 20 g/l, tryptone 2 g/l, KH [4] .
Animals and Breeding Conditions
All experiments were performed on male C57BL/6J ob/ob mice purchased from Japan SLC (Hamamatsu, Japan) and left to acclimatize for 2 weeks before experiment. The breeding room was maintained under a constant 12-h light: 12-h dark cycle with a temperature of 23±2 o C and relative humidity of 55±5% throughout the experimental period. They were given free access to standard pellets (Sam Yang, Seoul, Korea) and water. These experiments were approved by the Committee for Laboratory Animal Care and Use, Daegu University. All procedures were conducted in accordance with the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health.
Experimental Design
All the animals were randomly divided into two groups with seven animals in each group: The control group received 0.9% NaCl solution; the diabetic groups were treated with 200 mg/kg EPS from T. fuciformis (EPS) daily for 52 days. Fasting blood glucose levels and body weight were measured after fasting the animals for 4 h (starting from 10:00 A.M.). Glucose levels in the tail-vein whole blood samples were determined at 2:00 P.M. using a glucose analyzer (Lifescan, Milpitas, CA, U.S.A.).
Preparation of the Plasma Sample
Blood samples were obtained by resecting the terminal 1-2 mm of the mice' tails; a total of 0.5-0.6 ml of blood was drawn into sodium tubes containing EDTA. Plasma was separated by centrifugation (3,000 ×g, 10 min) and then stored at -30 o C until analysis. The protein content of plasma sample was determined by the Bradford method [2] using protein assay dye reagent concentrate (Bio-Rad, Hercules, CA, U.S.A.).
Two-Dimensional Gel Electrophoresis
Two-DE images were made in duplicate for three mice in each experimental group (totally 24 gel images for each group) on days 0 and 52. 2-DE images were normalized prior to statistical analysis. IPG IEF of samples was carried out on pH 4-7, 17 cm IPG DryStrips in the PROTEIN IEF cell (Bio-Rad) using the protocol recommended by the manufacturer. The IPG strips were rehydrated passively overnight in strip holders in 350 µl of rehydration solution containing 3 µl of plasma sample. IEF was carried out as follows: 15 min at 250 V, 3 h at 250-10,000 V, 6 h at 10,000 V, and then held at 500 V until ready to run the second dimension. Briefly, 400 µg (~3 µl) of the plasma sample was mixed with 347 µl of rehydration solution containing 7 M urea, 2 M thiourea, 4% CHAPS, 1 mM PMSF, 20 mM DTT, and 2% IPG buffer. After focusing, the gel strips were equilibrated in a solution containing 6 M urea, 2% SDS, 1% DTT, 30% glycerol, and 50 mM Tris-HCl (pH 6.8) for 15 min, followed by further incubation in the same solution, except for replacing DTT with 2.5% iodoacetamide for an additional 15 min. The equilibrated IPG strips were then gently rinsed with electrophoresis buffer. The gel strips were then placed on a 20×20 cm 12% polyacrylamide gel for resolution in the second dimension. The fractionation was performed with the Laemmli SDS-discontinuous system, at a constant voltage of 20 mA per gel for 10 h, after which the separated gels were visualized by silver staining.
Image Acquisition and Data Analysis
Gels were imaged on a UMAX PowerLook 1120 (Maxium Technologies, Inc., Taipei, Taiwan) and the resulting 16-bit images were converted to TIF format prior to export and analysis. Intensity calibration was carried out using an intensity stepwedge before gel image capture. Comparison of the images was performed using a modified version of ImageMaster 2D software V4.95 (Amersham Biosciences, Little Chalfont, Buckinghamshire, England). A reference gel was selected at random from the gels of the control group for each experiment, and detected spots from the other gels in the control data set were matched to those in the selected reference gel. The relative optical density and relative volume were also calculated in order to correct for differences in gel staining. Each spot intensity volume was processed by background subtraction and total spot volume normalization; the resulting spot volume percentage was used for comparison.
Enzymatic Digestion of Protein in the Gel
Protein spots were enzymatically digested in the gel in a manner similar to that previously described by Shevchenko et al. [50] using modified porcine trypsin. Gel pieces were washed with 50% acetonitrile to remove SDS, salts, and stain. The gel was then dried to remove solvent, rehydrated with trypsin (8-10 ng/µl), and incubated for 8-10 h at 37 o C. The proteolytic reaction was terminated by adding 5 µl of 0.5% trifluoroacetic acid. Tryptic peptides were recovered by combining the aqueous phase from repeated extractions of gel pieces with 50% acetonitrile. After concentration, the peptide mixture was redissolved in the buffer and desalted using C 1 8 ZipTips (Millipore, Watford, Herts, U.K.), and the peptides were eluted with 1-5 µl of acetonitrile. An aliquot of this solution was mixed with an equal volume of saturated solution of α-cyano-4-hydroxycinnamic acid in 50% acetonitrile, and 1 µl of the mixture was spotted onto a target plate.
Protein Identification
Protein analysis was performed using an Ettan MALDI-TOF (Amersham Biosciences). The peptides were evaporated with a N 2 laser at 337 nm using a delayed extraction mode. They were accelerated with a 20 kV injection pulse for a time-of-flight analysis. Each spectrum was the cumulative average of 300 laser shots. The search program, ProFound, developed by The Rockefeller University (http://129.85.19.192/ profound_ bin/ WebProFound.exe), was used for protein identification by peptide mass fingerprinting. Spectra were calibrated with trypsin autodigestion ion peak m/z (842.510, 2211.1046) as internal standards. Keratin contamination peaks and trypsin ion peak m/z (1045) were excluded from the list if at least two different keratins were identified from the same sample. Peptide masses were matched with the theoretical peptides of all proteins in the NCBI database using the Mascot search program (http://www.matrixscience.com). The following parameters were used for the database search: trypsin as cleaving enzyme; a maximum of one missed cleavage; 0.01% of maximum as peak threshold; iodoacetamide (Cys) as a complete modification; methionine as a partial modification; monoisotopic masses; and a mass tolerance of ±0.1 Da.
Western Blot Analysis
The differentially regulated levels of the eight proteins of interest were further confirmed by Western blot analysis as described below. An aliquot of plasma (70 µg) was diluted in 2× sample buffer [50 mM Tris (pH 6.8), 2% SDS, 10% glycerol, 0.1% bromophenol blue, and 
RNA Isolation
Total RNA from the liver, adipose, and muscle tissues of 3 different ob/ob mice in each experimental group was isolated with the RNeasy Protect Mini Kit and RNeasy Lipid Tissue Mini Kit (Qiagen, Stanford, CA, U.S.A.). Pelleted cells were resuspended in buffer RLT (liver tissue), QIAzol lysis reagent (adipose and skeletal muscle tissues), and homogenized by passing the lysate 5 times through a 20-gauge needle fitted to a syringe. The samples were then processed according to the manufacturer's instructions. In the final step, the RNA was eluted with 50 µl of RNase-free water by centrifugation for 1 min at 10,000 rpm. The quality of the RNA was analyzed on a 1% agarose gel and the concentration by a Qubit quantitation system (Invitrogen, Eugene, Oregon, U.S.A.).
The RT
2
Profiler PCR Array System For PCR array experiments, the Mouse Diabetes RT 2 PCR Array Profiler (Cat. No. APMM-023B; http://www.superarray.com) was used. The PCR array was a 96-well plate containing primers for a set of 89 related genes, including five housekeeping genes and three controls. The PCR array was performed according to the protocol recommended by the manufacturer (SuperArray Bioscience Co., Frederick, MD, U.S.A.). Briefly, the experimental RNA samples were converted into a PCR template with the RT 2 First Strand Kit. Then, the template was combined with an instrument-specific and ready-touse RT 2 Real-Time SYBR Green PCR Master Mix. Equal aliquots of this mixture (25 µl for 96-well) were added to each well of the same PCR array plate containing the pre-dispensed gene-specific primer sets, and a PCR was performed. Each reaction included 40 ng of total RNA and the proper negative controls (no reverse transcription, no template). RNA from the liver, adipose, and skeletal muscle tissues was analyzed in triplicate, and data were normalized for GAPDH levels by the ∆∆Ct method.
Statistical Analysis
All experimental results were compared by one-way analysis of variance (ANOVA) using the Statistical Package of Social Science (SPSS) program, and the data were expressed as means±SE. Group means were considered to be significantly different at p<0.05, as determined by the technique of protective least-significant difference (LSD) when ANOVA indicated an overall significant treatment effect (p<0.05).
RESULTS
Protein Profiling on 2-DE
To identify differentially expressed proteins, plasma proteins were separated on 2-DE combined with in-gel digestion of proteins and identified by MALDI-TOF-MS of high confidence based on high scores and sequence coverage. As shown in Fig. 1 , more than 900 individual spots were detected in the plasma protein map, ranging from 6 to 200 kDa masses between pH 4 and 7. The proteomic analysis demonstrated that 92 spots from a total of about 900 matched spots were differentially expressed, of which 40 spots have been previously identified as diabetesassociated proteins (Table 1 Coverage: percent of identified sequence to the complete sequence of the known protein.
c Z score corresponds to the percentile of the search in the random match population: Z score 1.65=95%, 2.33=99%, 3.09=99.9% confidence.
To suggest a molecular mechanism for the improvement of glucose profile by EPS, the plasma levels of adiponectin and resistin that were not detected by 2-DE were further studied by Western blot analysis (Fig. 4) . Resistin was downregulated but adiponectin was upregulated by EPS treatment.
Analysis of the Mouse Diabetes RT
2 PCR Array To investigate the differential gene expression patterns in the liver, adipose tissue, and muscle of ob/ob mice in response to EPS treatment, the Mouse Diabetes PCR Array was performed in triplicate. As shown in Fig. 5 and Table 2 , the expression level of many genes related to the onset, development, and progression of diabetes was significantly downregulated by EPS. The responsive genes could be divided into six functional categories: (1) receptors, transporters, and channels; (2) nuclear receptors; (3) metabolic enzymes; (4) secreted factors; (5) signal transduction proteins; and (6) transcription factors. On the whole, the number of genes downregulated was higher than those upregulated after EPS treatment in all three tissues, particularly in the liver and muscle (Fig. 5) . Of the 89 genes tested, the expressions of 34 genes were decreased and that of 2 genes increased after EPS treatment in all three tissues (data not shown). In Table 2 , genes showing extremely altered expression by EPS are listed. The expressions of Cd28, Foxc2, p38 MAPK, Nfkb1, Retn, and tumor necrosis factor (TNF) were significantly downregulated in all tissues, in response to EPS treatment. In contrast, there were no coherent changes in the expression of Mapk8 (JNK1) and peroxisomeproliferator-activated receptor alpha (PPARa).
DISCUSSION
On the Significance of Lipid Metabolism Proteins
One of the main features of insulin resistance includes dyslipidemia, which is characterized by high triglyceride, A. Volume density analysis graphs: data (mean ± SEM) are expressed as fold change between EPS-treated and control mice. Significant differences are indicated: *p<0.05 control vs. EPS-treated mice; **p<0.001 control vs. EPS-treated mice. B. 2-DE gel images of selected spots. C. Normal control mice group received 0.9% NaCl solution; EPS, diabetic mice group treated with Tremella fuciformis 200 mg/kg EPS using an oral administration daily for 52 days. Band density was digitized with software and the mean±SE of three independent experiments are shown. *p<0.05 control vs. EPS; **p<0.001 control vs. EPS-treated mice. Notations for each group are the same as in Fig. 2 .
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low high-density lipoprotein (HDL), and small and dense low-density lipoprotein (LDL) in the blood [13] . In our previous study, we found that EPS from T. fuciformis significantly increased lipid metabolism in ob/ob mice [3] . Thus, we first examined the changes of the protein related to the lipid metabolism such as apolipoproteins (Apo) A, C, and E, because exchangeable Apo plays critical roles in lipid transport and lipoprotein metabolism in diabetic subjects.
In animal models of diabetes and in cell cultures treated with high concentrations of glucose, apo A-I expression is reduced [25] . Since the major lipoprotein constituents of HDL are apo A-I and A-II, identifying the mechanisms that modulate apo A-I gene expression will contribute to the new development of therapeutic agents that increase plasma apo A-I and HDL concentrations.
The activation of adenosine monophosphate-activated protein kinase (AMPK) leads to an increase in glucose uptake in skeletal muscle and a decrease in gluconeogenesis in the liver [6] . Through this mechanism, apo A-I stimulates glucose utilization and improves insulin resistance in peripheral tissues. In this regard, an increase in apo A-I after EPS treatment in this study has a dual protective effect in type 2 diabetes mellitus (T2DM), both by lowering the prevalence of diabetes-associated cardiovascular diseases and improving insulin resistance via activation of AMPK. In this respect, apo A-I seems to be an ideal target for the prevention and therapy of T2DM and the metabolic syndrome. However, it remains unclear at present whether HDL and/or apo A-I directly protect against diabetes, and if so, what the underlying molecular mechanism is.
Blood levels of apo A-IV generally correlate with triglyceride levels and are increased in diabetic patients. Few studies have attempted to elucidate the regulation of apo A-IV at the promoter level [17] . Apo C-III is the most abundant apolipoprotein in very low-density lipoprotein (VLDL) particles and is correlated closely with concentrations of serum total and VLDL triglycerides [20] . This protein modulates metabolism of triglyceride-rich lipoproteins (TRLs) at two subsequent steps. Firstly, apo C-III is an inhibitor of lipoprotein lipase activity, and secondly, it interferes with apolipoprotein E-mediated receptor binding, delaying removal of remnant particles. To date, little attention has been paid to the distribution of apo C-III between VLDL subspecies. Likewise, only a few studies have reported apo C-III levels in a diabetic population [20] . These reports emphasize the Band density was digitized with software and the mean±SE of three independent experiments are shown. *p<0.05 control vs. EPS-treated mice; **p<0.001 control vs. EPS-treated mice. Notations for each group are the same as in Fig. 2 . 
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PROTEOMIC ANALYSIS IN OB/OB MICE 9 need to study the distribution and composition of VLDL subclasses separately to capture the atherogenicity of TRL subpopulations in T2DM. In the present study, the expression of apo A-IV was decreased, whereas that of apo C-III was unexpectedly increased in EPS-treated mice, which is probably attributable to the enhanced lipid metabolism. Apo E is a glycoprotein that circulates as a surface component of plasma lipoproteins and is expressed in numerous mammalian cell types [63] . Reports over many years have demonstrated that apo E is involved in maintaining important aspects of organismal and cellular homeostasis. For example, disordered apo E function/expression has a well-established role in the pathophysiology of important human diseases such as atherosclerosis and dementia [5, 37] . Apo E is involved in HDL metabolism, as demonstrated by decreased plasma clearance of HDL-cholesteryl ester in apo E knock-out mice [18] . The associations between plasma apo A-I and E concentrations and phospholipids transfer protein (PLTP) activity suggest that these apolipoproteins are important regulators of PLTP activity in vivo [55] . The increase in PLTP activity in T2DM is partly related to the changes in these apolipoproteins. The decreased level of apo E after EPS treatment in this work implies a positive role in HDL metabolism.
Adiponectin is a peptide predominantly synthesized in the adipose tissue that plays an important role in carbohydrate and lipid metabolism and vascular biology [41, 58, 61] . Plasma adiponectin levels are reduced in individuals with abdominal obesity, metabolic syndrome, and/or T2DM [41] . Thus, adiponectin concentration has been found negatively correlated with abdominal obesity and insulin resistance in humans and has been shown to predict the development of T2DM. Adiponectin is also related to lipid metabolism, principally high levels of HDL cholesterol and lower levels of triglycerides. The mechanism for the association between plasma adiponectin and HDL cholesterol is still unknown and has not been previously investigated.
Furthermore, adiponectin stimulates glucose metabolism by promoting the phosphorylation and activation of adenosine monophosphate activation of adenosine monophosphateactivated protein kinase (AMPK), a stress-responsive kinase, in skeletal muscle, liver, and adipocytes [44] . It was suggested that down regulation of the adiponectin-AMPK regulatory pathway may participate in endothelial cell dysfunction and vessel rarefaction that are observed in obese states and T2DM. Taken together, increased adiponectin level in EPStreated mice supported a hypothesis that EPS played a critical role in AMPK activation, thereby promoting insulin sensitivity in ob/ob mice.
On the Significance of Retinol-Binding Protein 4 and Transferrin More recently, it has been demonstrated that elevated serum RBP4 levels are associated with many metabolic syndromes such as obesity and T2DM [10, 14, 60, 62] . For example, increased levels of serum RBP4 led to impaired glucose uptake into skeletal muscle and increased glucose production by the liver, whereas lowered serum RBP4 levels greatly enhanced insulin sensitivity [60] . It has been reported that adipocyte GLUT4 protein and serum RBP4 levels were inversely correlated. Although the molecular evidence for the relationship between these two molecules is not clarified yet, it might involve sensing of glucose by adipocytes [14] . Moreover, RBP4 is an adipocyte-secreted molecule that is elevated in the serum before the development of overt diabetes and predicts insulin resistance and associated cardiovascular risk factors in subjects with varied clinical presentations [14] . In this study, the plasma level of RBP4 was significantly decreased in EPS-treated ob/ob mice, suggesting the possibility of EPS as a possible antidiabetic agent for lowering the serum RBP4 levels.
Plasma transferrin itself may be involved in the pathogenesis of insulin resistance because it has an antagonistic effect on insulin action [57] . A recent study showed that transferrin is a major determinant of the lipolytic activity of human serum in adipocytes [47] . An increase in adipose tissue lipolysis due to higher transferrin levels could increase availability of free fatty acids to the liver and skeletal muscle, which could in turn lead to insulin resistance. Accordingly, elevated serum transferrin by EPS treatment suggests the stimulatory role of this molecule in lipolysis, which probably occurs through a prooxidant mechanism mediated by iron.
On the Significance of Cytokines
Adipocytes produce numerous hormones and cytokines such as TNF-α, plasminogen activator inhibitor type 1 (PAI-1), leptin, adiponectin, and resistin. These factors play an important role locally (within adipose tissue) but may also have important effects as circulating bioactive factors [38] . The ability of adipokines such as resistin to directly modulate endothelial function and incite endothelial activation may represent an important link between insulin resistance and cardiovascular disease [35, 56] . However, the role of resistin in insulin sensitivity and obesity is still controversial. For example, some authors suggested that increased serum resistin levels were associated with obesity, insulin resistance in T2DM, and inflammation, whereas others failed to observe such correlations. Plasma resistin levels were highly positively correlated with triglycerides, waist circumference, waist/hip ratio, systolic blood pressure, and apo A-I/apo B ratio, whereas they were inversely correlated with high-density lipoprotein and apo A-I levels [42] . Resistin was also identified by screening the genes that were induced during the differentiation of the adipocytes exposed to PPARγ ligands. Taken together, it is likely that serum resistin level is associated with insulin sensitivity, suggesting that resistin plays an important role in the development of insulin resistance in T2DM patients [35, 56] . The markedly reduced levels of resistin after EPS treatment in the present study is another evidence for the preventive role of EPS in diabetic mice.
Functional Analysis by PCR Array System Global gene expression, or transcriptional profiling, has been used to identify molecular markers for various pathological states, and can be used to generate novel hypotheses [8, 23, 24, 39] . DNA microarrays have been used to identify candidate genes for disease diagnosis and to characterize gene expression patterns associated with potential disease treatments including diabetes [12, 21, 24, 39, 59] . However, the genetic changes involved in the pathologenesis of diabetes have not been fully identified so far [67] . To date, there is still a lack of knowledge about the changes in gene expression in diabetic subjects before and after treatments with antidiabetic drugs or other candidate materials.
Nadler et al. [40] have employed DNA microarrays to identify differences in gene expression between the adipose tissue from lean, obese, and that from obese-diabetic mice. By using different strains of mice, they were able to identify those genes whose expression changed regardless of the strain background and are therefore most likely to be relevant to obesity and diabetes. Of the over 11,000 genes examined, over 200 showed consistent changes with obesity. Another DNA microarray approach provided several candidate genes for muscle insulin resistance, complications associated with poor glycemic control, and effects of insulin treatment in T2DM [53] . The expression of five genes (e.g., MHC-I, GLUT4, IGFBP-5, SOD2, and UCP-3) significantly changed in T2DM patients compared with the control subjects.
RT² Profile PCR Arrays are the most reliable and sensitive gene expression profiling technology for analyzing a panel of genes in signal transduction pathways, biological processes, or disease-related gene networks. More recently, the PCR arrays have been used for research on cancer, diabetes, immunology, toxicology, biomarker discovery and validation, and phenotypic analysis of cells and transgenic animals [1, 16, 43, 45, 64, 66] . The Mouse Diabetes RT² Profile PCR Array profiled the expression of 84 genes related to the onset, development, and progression of diabetes. They include genes that contribute to obesity, insulin resistance, the early onset of diabetes, and complications from diabetes mellitus. It is interesting to mention that the number of genes downregulated was much higher than those upregulated, in response to EPS treatment in all three tissues of ob/ob mice, particularly in the liver and muscle. Therefore, this result is strong evidence for the hypoglycemic role of EPS in ob/ob mice at the gene level, and is the first report showing that EPS directly signals rat tissues to regulate the expression of many important diabetes-related genes.
Among 84 diabetes genes, 7 genes (JNK1, Tnf, Nfkb1, p38 MAPK, PPARα, Retn, and Cd28) would significantly contribute to amelioration of the diabetic condition in ob/ ob mice by EPS treatment. JNK (Jun N-terminal kinase) deficiency is protective in different mouse models of obesity-induced glucose intolerance because it increases the sensitivity of target tissues to insulin [9, 19, 51] . Interestingly, our results indicate that JNK in adipose tissues strongly decreased, whereas the level in muscle tissues and liver increased in ob/ob mice by EPS treatment. Elevated production of tumor necrosis factor (TNF)-α by adipose tissue decreases sensitivity to insulin and has been detected in several experimental obesity models and obese humans [9] . Free fatty acids (FFAs) are also implicated in the etiology of obesity-induced insulin resistance, although the molecular pathways involved in their action remain unclear [51] .
In skeletal muscle, TNF-α induces insulin resistance via the p38 MAPK pathway [49] . The reason for the elevation of TNF-α in T2DM is still unclear. Some have ascribed it to increased adiposity associated with T2DM and the consequence of fat cell-dependent TNF-α production [22, 34, 36] . Igarashi et al. [22] suggested p38 MAPK as a possible target in vascular cells, which can be activated by high glucose levels and diabetes. In addition, these findings support those of Kotlyarov et al. [34] who showed that lipopolysaccharide (LPS)-induced TNF-α production was dependent on posttranscriptional modifications regulated by MAPKAP kinase 2, a kinase directly downstream of p38 kinase, and not to changes in mRNA expression and stability. Insulin-dependent activation of PI3K is reduced in T2DM. It is likely that decreased p38 MAPK levels by EPS will have biologic and possible pathologic importance in the preservation of diabetic vascular complications. It is probable that some of these changes by EPS treatment are related to the changes in circulating substrates such as glucose, fatty acids, and amino acids.
